clinical study of the autologous oral mucosal epithelial cell sheets in preventing formation of strictures after endoscopic submucosal dissection for esophageal cancer
Phase 1
- Conditions
- Esophageal narrowing after ESD
- Registration Number
- JPRN-UMIN000038051
- Lead Sponsor
- okinawa prefecture
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
I) Patients with complications of poor control (Heart disease, liver disease, kidney disease, cerebral infarction, etc.). I) Pregnancy, breastfeeding, and patients with the possibility of pregnancy (will). I) Patients with a history of severe drug allergies. Ii) Patients infected with infectious diseases (hepatitis B, hepatitis C, HIV, HTLV-1, syphilis). I) Patients who have a disease in the oral mucosa of the tissue collection site and cannot be collected. Ii) Other patients who are judged inappropriate by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety of Oral Mucosal Epithelial Cell Sheet
- Secondary Outcome Measures
Name Time Method Preventive effect of esophageal narrowing by oral mucosal epithelial cell sheet transplantation